Although the reasons for these poor benefits have yet to be elucidated, Ganior et al. reported that EGFR-/ALK-mutated patients had low PD-L1 expression and a low presence of CD8+ TILs, which was described as a “cold” tumor microenvironment [109]. This evidence concerns the gene CD8A and neoplasm.